Nat Rev Drug Discov. 2006 Mar;5(3):197-209.

Evolving knowledge and therapy of inflammatory bowel disease.

Source

Gastrointestinal Unit, Department of Medicine, Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Boston, Massachusetts 02114, USA.

Abstract

With recent advances in the understanding of its pathophysiology, inflammatory bowel disease has become a very active area for the development of novel therapeutic agents. New targets for biologics include cytokines involved in T-cell activation, with antibodies directed against IL-12 and interferon-gamma. Selective adhesion molecule blockade has produced promising, though mixed, results. Recombinant human granulocyte-macrophage colony-stimulating factor might be effective in active Crohn's disease, presumably through stimulation of intestinal innate immune responses. With increasing evidence for a crucial role for luminal flora in maintaining the health of the bowel, strategies to manipulate intestinal bacteria using probiotics and prebiotics are being actively investigated as well.

PMID:: 16518373; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Supplemental Content

Related citations

Review Biologic therapy for inflammatory bowel disease. [Drugs. 2005]
Review Biologic therapy for inflammatory bowel disease.
Ardizzone S, Bianchi Porro G. Drugs. 2005; 65(16):2253-86.
Review Novel strategies to attenuate immune activation in Crohn's disease. [Curr Opin Pharmacol. 2006]
Review Novel strategies to attenuate immune activation in Crohn's disease.
Bamias G, Cominelli F. Curr Opin Pharmacol. 2006 Aug; 6(4):401-7. Epub 2006 Jun 5.
Review Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease. [Expert Opin Ther Targets. 2008]
Review Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
Mitsuyama K, Sata M. Expert Opin Ther Targets. 2008 Mar; 12(3):301-12.
Review The therapeutic impact of manipulating microbiota in inflammatory bowel disease. [Curr Pharm Des. 2009]
Review The therapeutic impact of manipulating microbiota in inflammatory bowel disease.
Kanauchi O, Mitsuyama K, Andoh A. Curr Pharm Des. 2009; 15(18):2074-86.
Review Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics. [Rev Recent Clin Trials. 2008]
Review Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.
Heilpern D, Szilagyi A. Rev Recent Clin Trials. 2008 Sep; 3(3):167-84.

See reviews... See all...

Cited by 14 PubMed Central articles

Enhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosa. [PLoS One. 2011]
Enhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosa.
Harel E, Rubinstein A, Nissan A, Khazanov E, Nadler Milbauer M, Barenholz Y, Tirosh B. PLoS One. 2011; 6(9):e24202. Epub 2011 Sep 6.
Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis. [Mol Med. 2011]
Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.
Guan Q, Ma Y, Hillman CL, Qing G, Ma AG, Weiss CR, Zhou G, Bai A, Warrington RJ, Bernstein CN, et al. Mol Med. 2011; 17(7-8):646-56. Epub 2011 Mar 11.
Review Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases. [World J Gastroenterol. 2011]
Review Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.
Bouguen G, Chevaux JB, Peyrin-Biroulet L. World J Gastroenterol. 2011 Feb 7; 17(5):547-56.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Evolving knowledge and therapy of inflammatory bowel disease.
Evolving knowledge and therapy of inflammatory bowel disease.
Nat Rev Drug Discov. 2006 Mar ;5(3):197-209.

PubMed
NX-1207: a novel investigational drug for the treatment of benign prostatic hype...
NX-1207: a novel investigational drug for the treatment of benign prostatic hyperplasia.
Expert Opin Investig Drugs. 2010 Feb ;19(2):305-10.

PubMed
Impaired angiogenesis in aminopeptidase N-null mice.
Impaired angiogenesis in aminopeptidase N-null mice.
Proc Natl Acad Sci U S A. 2007 Mar 13 ;104(11):4588-93. Epub 2007 Mar 7 .

PubMed
The comparative effects of telmisartan and ramipril on P-wave dispersion in hype...
The comparative effects of telmisartan and ramipril on P-wave dispersion in hypertensive patients: a randomized clinical study.
Clin Cardiol. 2005 Jun ;28(6):298-302.

PubMed
Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor liga...
Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis.
J Pharmacol Exp Ther. 2005 May ;313(2):604-12. Epub 2005 Jan 11 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Evolving knowledge and therapy of inflammatory bowel disease.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Related citations

Cited by 14 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information